---
_schema: default
id: 65835
date: 2024-11-29
title: >-
    What claims were made by ENTOD Pharmaceuticals regarding their eye drops?
article_title: >-
    What claims were made by ENTOD Pharmaceuticals regarding their eye drops?
date_format: MMM DD, YYYY
post_on_text: Posted on
seo:
  title: QuickTakes | Medicine
  page_description: >-
    This content discusses the claims made by ENTOD Pharmaceuticals about PresVU eye drops as a treatment for presbyopia, the regulatory scrutiny it faced from the DCGI, and the controversies surrounding the product's efficacy and novelty.
  page_keywords: >-
    ENTOD Pharmaceuticals, PresVU eye drops, presbyopia treatment, reading glasses, drug regulation, misleading claims, DCGI suspension, pilocarpine, India, eye health
author: QuickTakes
question: >-
    What claims were made by ENTOD Pharmaceuticals regarding their eye drops?
answer: >-
    ENTOD Pharmaceuticals, a Mumbai-based company, made several claims regarding its product, PresVU eye drops, which were marketed as a treatment for presbyopia, a condition characterized by difficulty in seeing close objects. The company described PresVU as a "proud Indian innovation" and asserted that it could significantly reduce the dependency on reading glasses for individuals suffering from this condition.\n\nHowever, these claims have been met with significant scrutiny and criticism. The Drugs Controller General of India (DCGI) suspended the permission for ENTOD to manufacture and sell PresVU, citing that the company had made misleading claims about the product's capabilities. Specifically, the DCGI noted that ENTOD had not obtained the necessary approvals for the claims it made regarding the eye drops. An official source described the presentation of these claims as "unethical and false," emphasizing that the company failed to respond adequately to inquiries regarding the product's efficacy.\n\nMoreover, the main active ingredient in PresVU, pilocarpine, has been available in India for decades, raising questions about the novelty of the treatment being offered. The DCGI's order highlighted that ENTOD had overstated the product's capabilities, particularly in relation to its ability to eliminate the need for reading glasses.\n\nIn summary, while ENTOD Pharmaceuticals promoted PresVU eye drops as a groundbreaking solution for presbyopia, regulatory actions have revealed that the claims were not substantiated by the necessary approvals, leading to a suspension of the product's manufacturing and marketing license.
subject: Medicine
file_name: what-claims-were-made-by-entod-pharmaceuticals-regarding-their-eye-drops.md
url: /learn/medicine/questions/what-claims-were-made-by-entod-pharmaceuticals-regarding-their-eye-drops
score: -1.0
related_article1:
    id: 65843
    title: >-
        What concerns have been raised by the Women in Cinema Collective?
    subject: Sociology
    url: /learn/sociology/questions/what-concerns-have-been-raised-by-the-women-in-cinema-collective
related_article2:
    id: 65834
    title: >-
        What were the specific reasons for the suspension of ENTOD Pharmaceuticals' eye drops?
    subject: Medicine
    url: /learn/medicine/questions/what-were-the-specific-reasons-for-the-suspension-of-entod-pharmaceuticals-eye-drops
related_article3:
    id: 65860
    title: >-
        What are the implications of Brazil's Supreme Court decisions on X's operations?
    subject: Business and Management
    url: /learn/business-and-management/questions/what-are-the-implications-of-brazils-supreme-court-decisions-on-xs-operations
related_article4:
    id: 65836
    title: >-
        Were there any clinical trials conducted for ENTOD Pharmaceuticals' eye drops?
    subject: Medicine
    url: /learn/medicine/questions/were-there-any-clinical-trials-conducted-for-entod-pharmaceuticals-eye-drops
---

&nbsp;